Sixty-seven patients (6–45 years) with a phenylalanine tolerance ⩾600 mg/day were included in the study. From a 3-day diet record, protein supply as well as consumption of essential amino acids and ...

Cambrooke Therapeutics announced the launch of Glytactin RESTORE Powder and Glytactin RESTORE Lite Powder, new medical food hydration beverages for the dietary management of phenylketonuria (PKU).

Otsuka Pharmaceutical is broadening its scope in rare disease, striking a deal to acquire Jnana Therapeutics and its lead drug candidate, a small molecule on track for pivotal testing in a metabolic ...

Low phenylalanine (PHE), glycomacropeptide-based protein substitute (GMP) is an alternative to traditional L-amino acid supplements (AA) used in the dietary management of phenylketonuria (PKU). In a ...

Researchers in Germany recently evaluated executive functions in 36 patients who were diagnosed with PKU during childhood. Significant negative correlations were observed between elevated childhood ...

(RTTNews) - PTC Therapeutics, Inc. (PTCT) announced Wednesday that the primary endpoint was achieved in the APHENITY, Phase 3 registration-directed clinical trial of sepiapterin in adult and pediatric ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

To control their phenylalanine (Phe) levels, patients with PKU are advised to follow a restricted diet. However, little is known about the long-term consequences. A new study of 15 adults with PKU ...

BOSTON--(BUSINESS WIRE)--Cycle Pharmaceuticals (Cycle) has launched Cycle Vita PKU, an AI-powered app to help patients with PKU manage every aspect of their treatment plan. It can be challenging for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Aptatek BioSciences Inc. of Princeton develops in-home health monitoring products for patients with chronic disease. And an influx of new capital will help with that mission. On March 17, Aptatek ...

BioMarin Pharmaceuticals announced results from the PKU-016 ASCEND study, the largest randomized controlled study evaluating neuropsychiatric outcomes in phenylketonuria (PKU) patients treated with ...